Abstract
Doses of 5.0, 7.5 and 10.0 gl-tryptophan, the amino acid precursor of serotonin, or saline alone were administered by IV infusion to a group of 11 healthy male subjects, and both hormonal and behavioral responses were monitored. Significant increases were observed in plasma concentrations of growth hormone and prolactin after all three doses ofl-tryptophan, but not after saline infusion. No alterations in cortisol or thryotropin were noted at any level. Examination of behavioral effects ofl-tryptophan revealed a dose-dependent impairment in performance on the symbol copying test. In addition,l-tryptophan produced significant effects on mental and physical sedation, but did not alter subjective ratings of tranquilization. In agreement with some prior reports, these observations support the ability ofl-tryptophan, when administered IV in high doses, to produce pronounced effects on the central nervous system in humans, and suggest the potential utility of this paradigm as a neuroendocrine challenge test.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Anton-Tay F, Wurtman RJ (1971) Brain monoamines and endocrine function. In: Martini L, Ganong WF (eds) Frontiers in neuroendocrinology, Oxford University Press, New York, pp 45–66
Ashcroft GW, Crawford TBB, Eccleston D, Sharman DF, McDougall EJ, Stanton JG, Binns JK (1966) 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet 2:1049–1052
Bergstrom DA, Kellar KJ (1979) Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimpramine treatment. J Pharmacol Exp Ther 209:256–261
Bunney WE Jr, Davis JM (1965) Norepinephrine in depressive reactions. Arch Gen Psychiatry 13:483–494
Charney DS, Heninger GR, Reinhard JF (1982) The effect of intravenousl-tryptophan on prolactin and growth hormone and mood in healthy subjects. Psychopharmacology 77:217–222
Charney DS, Heninger GR, Sternberg DE (1984) Serotonin function and mechanism of action of antidepressant treatment. Arch Gen Psychiatry 41:359–365
Coppen AJ (1967) The biochemistry of affective disorder. Br J Psychiatry 113:1237–1264
Coppen A, Eccleston EG, Peet M (1973) Total and free tryptophan concentration in the plasma of depressive patients. Lancet 2:60–63
Curzon G, Kantameneni BD, Van Boxel P, Gillman PK, Bartlett JR, Bridges PK (1980) Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients. Acta Psychiatr Suppl 280:3–19
Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096–1121
Faber J, Hagen C, Kirkegaard C, Lauridsen UB, Muller SE (1977) Lack of effects ofl-tryptophan on basal and TRH-stimulated TSH and prolactin levels. Psychoneuroendocrinology 2:413–415
Fernstrom JD, Wurtman RJ (1971) Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173:149–152
Fernstrom JD, Wurtman RJ (1972) Brain serotonin content: Physiological regulation by plasma neutral amino acids. Science 178:414–416
Fraser WM, Tucker HSt, Grubb SR, Wigand JP, Blackard WG (1979) Effect ofl-tryptophan on growth hormone and prolactin release in normal volunteers and patients with secretory pituitary tumors. Horm Metab Res 11:149–155
Fuxe K, Butcher LL, Engel J (1971)Dl-5-Hydroxytryptophan-induced changes in central monoamine neurons after peripheral decarboxylase inhibition. J Pharm Pharmacol 23:420–424
Gillman PK, Bartlett JR, Bridges PK, Kantameneni BD, Curzon G (1980) Relationship between tryptophan concentrations in human plasma, cerebrospinal fluid and cerebral cortex following tryptophan infusion. Neuropharmacology 19:1241–1242
Glass AR, Smallridge RC, Schaff M, Diamond RC (1980) Absent prolactin response tol-tryptophan in normal and acromegalic subjects. Psychoneuroendocrinology 5:261–265
Greenwood MH, Friedel J, Bond AJ, Curzon G, Lader MH (1974) The acute effects of intravenous infusion ofl-tryptophan in normal subjects. Clin Pharmacol Ther 16:455–464
Handwerger S, Plonk JW, Lebovitz HE, Bivens CH, Feldman JM (1975) Failure of 5-hydroxytryptophan to stimulate prolactin and growth hormone secretion in man. Horm Metab Res 7:214–216
Heninger GR, Charney DS, Sternberg DE (1984) Serotonergic function in depression. Arch Gen Psychiatry 41:398–402
Imura H, Nakai Y, Yoshimi T (1973) Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man. J Clin Endocrinol Metab 36:204
Kato Y, Nakai Y, Imura H, Chihara K, Ohgo S (1974) Effect of 5-hydroxytryptophan (5-HTP) on plasma prolactin levels in man. J Clin Endocrinol Metab
Lal S, Young SN, Cervantes P, Guyda H (1980) Effect ofl-tryptophan on apomorphine-induced growth hormone secretion in normal subjects. Pharmakopsychiatrie 13:331–335
Lancranjan I, Wirz-Justice A, Puhringer D, Del Pozo E (1977) Effect ofL-v-hydroxytryptophan unfusion on growth hormone, and prolactin secretion in man. J Clin Endocrinol Metab 45:588–593
Lapin IP, Oxenkrug GF (1969) Intensification of the central serotonergic processes as a possible determinant of thymoleptic effect. Lancet 1:132–136
Lucki I, Frazer A (1985) Changes in behavior associated with serotonin receptors following repeated treatment of rats with antidepressant drugs. In: Seiden LS, Balster RL (eds) Alan Liss Co, New York, pp 339–357
MacIndoe JH, Turkington RW (1973) Stimulation of human prolactin secretion by intravenous infusion ofl-tryptophan. J Clin Invest 52:1972–1978
Mason JW (1968) A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosom Med 30:576–607
Meltzer HY, Wiita B, Tricou BJ (1982) Effect of serotonin precursors and serotonin agonists on plasma hormone levels. In: Ho BT, Schoolar JC, Usdin E (eds) Serotonin in biological psychiatry. Raven Press, New York, pp 117–138
Meltzer HY, Lowy M, Robertson A, Goodnick KP, Perline R (1984) Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders III. Effect of antidepressants and lithium carbonate. Arch Gen Psychiatry 41:391–397
Modlinger RS, Schonmueller JM, Arora SP (1980) Adrenocorticotropin release by tryptophan in man. J Clin Endocrinol Metab 50:360–363
Mueller EE, Brambilla F, Cavagnini F, Peracchi M, Panerai A (1974) Slight effect ofl-tryptophan on growth hormone release in normal human subjects. J Clin Endocrinol Metab 39:1–5
Norris H (1977) The action of sedatives on brain stem oculomotor systems in man. Neuropharmacology 10:181–191
Pare CMB, Sandler M (1959) A clinical and biochemical study of a trial of iproniazid in the treatment of depression. J Neurol Neurosurg Psychiatry 22:247–251
Peroutka SJ, Snyder SH (1980) Chronic antidepressant treatment lowers spiroperidal-labeled serotonin receptor binding. Science 210:88–90
van Praag HM (1974) Central monoamine deficiency in depressions: Causative or secondary phenomenon. Pharmakopsychiatry 8:321–326
van Praag HM (1978) Amine hypothesis of affective disorders. In: Iversen LL, Iversen SD, Snyder SH (eds) Biology of mood and antianxiety drugs, vol 13. Plenum Press, New York, pp 187–297
van Praag HM, Korf J, Puite J (1970) 5-Hydroxyindoleacetic acid levels in the cerebrospinal fluid of depressive patients treated with probenecid. Nature 225:1259–1260
Savage DD, Mendels J, Frazer A (1980) Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects of [H3] serotonin binding sites in rat brain. J Pharmacol Exp Ther 212:259–263
Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122:509–522
Segal DS, Kuczenski R, Mandell DJ (1974) Theoretical implications of drug-induced regulation for a biogenic amine hypothesis of affective disorder. Biol Psychiatry 9:147–159
Smythe GA, Compton PJ, Lazaru L (1976) Serotonergic control of human growth hormone secretion: The actions ofl-dopa andz-bromoergocrytise. In: Pecile A, Muller EE (eds) Growth hormone and related peptides. Excerpta Medica, Amsterdam, pp 222–235
Strom-Olsen R, Weil Malherbe H (1958) Humoral changes in manic-depressive psychosis with particular reference to excretion of catecholamines in urine. J Ment Sci 104:696–704
Wechsler D (1955) Manual for the wechsler adult intelligence scale. The Psychological Corporation, New York
Weitzman ED, Fukashima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L (1971) The twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 33:14–22
Westenberg HGM, van Praag HM, de Jong JTVM, Thijssen JHH (1982) Postsynaptic serotonergic activity in depressive patients: evaluation of the neuroendocrine strategy. Psychiatr Res 7:361–371
Winokur A, Amsterdam JD, Caroff S, Snyder PJ, Brunswick D (1982) Variability in hormonal response to a series of neuroendocrine challenges (TRH, GnRH, ITT, DST) in depressed patients. Am J Psychiatry 139:39–44
Wirz-Justice A, Purhringer W, Lacoste V, Graw P, Gastpar M (1976) Intravenous 1-5-hydroxytryptophan in normal subjects: an interdisciplinary precursor loading study. Pharmakopsychiatrie 9:277–288
Woolf PD, Lee L (1977) Effect of the serotonin precursor, tryptophan, on pituitary hormone secretion. J Clin Endocrinol Metab 45:123–133
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Winokur, A., Lindberg, N.D., Lucki, I. et al. Hormonal and behavioral effects associated with intravenousl-tryptophan administration. Psychopharmacologia 88, 213–219 (1986). https://doi.org/10.1007/BF00652243
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00652243